PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 25: Articles 12001-12500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Oral contraceptives and metabolic risk markers for coronary heart disease.
  2. Oral contraceptives and neoplasia of the ovary.
  3. Oral contraceptives and neoplasia of the uterine corpus.
  4. Oral contraceptives and reproductive system cancer: benefits and risks.
  5. Oral contraceptives containing desogestrel in the maintenance of the remission of hirsutism: monthly versus bimonthly treatment.
  6. Oral contraceptives in the etiology of isolated hypospadias.
  7. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
  8. Ovarian response in superovulated cycles after suppression with oral contraceptive steroids.
  9. Patterns of research: oral contraceptives and cervical cancer.
  10. Phase II -- clinical trial with biodegradable subdermal contraceptive implant Capronor (4.0-cm single implant)
  11. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
  12. A pilot study on the assessment of a progesterone / estradiol sustained release as once-a-month-injectable contraceptive.
  13. Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinylestradiol.
  14. Preference for male children and contraceptive use in Taiwan.
  15. Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.
  16. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
  17. Public funding of contraceptive, sterilization and abortion services, fiscal year 1990.
  18. A regional referral clinic for intrauterine contraceptive device (IUD) removal problems.
  19. The risk of liver neoplasia in relation to combined oral contraceptive use.
  20. The role of contraception in the development of postmolar gestational trophoblastic tumor.
  21. Sexual activity and attitudes toward contraception among women seeking termination of pregnancy in Zaria, Northern Nigeria.
  22. Sexual activity, contraceptive practice and abortion among adolescents in Lagos, Nigeria.
  23. Sexual experience, abortion and sexually transmitted diseases among young women at a contraceptive clinic.
  24. Studies on the pharmacokinetics of contraceptive steroids under steady-state conditions. [Untersuchungen zur Pharmakokinetik kontrazeptiver Steroide unter den Bedingungen der Langzeiteinnahme.]
  25. Targeted HIV screening at a Los Angeles prenatal / family planning health center.
  26. Testicular suspension as a method of male contraception: technique and results.
  27. Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent, Deposiston. Hormonal contraceptives and caffeine elimination. [Zeitverlauf der Hemmung der Coffeinelimination unter dem Einfluss des oralen Depotkontrazeptivum Deposiston. Hormonale Kontrazeptiva und Coffeinelimination.]
  28. Time required for a healthy couple to achieve conception, contraceptive behavior, and rate of preceding infertility therapy. An epidemiologic study of 750 consecutive patients in labor at the Oldenburg Gynecologic Clinic using a structured interview. [Kinderwunschdauer, kontrazeptives Verhalten und Rate vorausgegangener Infertilitatsbehandlungen. Eine epidemiologische Untersuchung bei 750 konsekutiv erfassten Wochnerinnen der Oldenburger Frauenklinik durch strukturiertes Interview.]
  29. Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease.
  30. Use-effectiveness among users of the symptothermal method of family planning.
  31. In utero exposure to steroid contraceptives and outcome of pregnancy.
  32. In utero exposure to steroid contraceptives and survival during infancy.
  33. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries.
  34. Applying lessons learned in contraceptive social marketing to other essential health products.
  35. Paying for family planning./Le financement du planning familial./Como pagar el costo de la planificacion familiar.
  36. Handbook for family planning operations research design. 2nd ed.
  37. Health consequences of contraceptive use and reproductive patterns. Summary of a report from the US National Research Council.
  38. Health Ministry takes controversial step; anti-contraception conception.
  39. Health, education and family planning in the Philippines: governmental initiatives and household choice.
  40. Hebei circular on punishments for violating family planning policy [1990]
  41. Helping people to be involved in family planning.
  42. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use.
  43. HIV infection in women attending family planning clinics in Nairobi.
  44. HIV seroprevalence in clients of sentinel family planning clinics.
  45. Home, adolescent sexuality and family planning. [Hogar, sexualidad juvenil y planificacion familiar.]
  46. Homeless women's wholistic and family planning needs: an exposition and test of the nurse practitioner practice model.
  47. Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma.
  48. Hormonal contraception. [Gormonalnaia kontratseptsiia.]
  49. Hormonal contraceptives: does one dose fit all?
  50. Hormonal long-acting methods for contraception.
  51. Hormone replacement therapy in a community health family planning clinic.
  52. How to involve trade unions in family planning?
  53. Husbands' and wives' reports on fertility preferences and family planning in Ghana and Kenya.
  54. Hypertension through oral contraceptives, estrogens and gestagens. [Bluthochdruck durch orale Kontrazeptiva, Ostrogene und Gestagene.]
  55. IAP-IPA-WHO-UNICEF Workshop on Strategies and Approaches for Women's Health, Child Health and Family Planning for the Decade of Nineties, 22nd-23rd January 1991, Hyderabad.
  56. Identification of clinical and programmatic research needs in postpartum contraception. Report on the International Conference on Postpartum Contraception, Mexico City, September 1990.
  57. Immunocontraception -- a family planning possibility of the future. [Immunkontraception -- framtida mojlighet till familjeplanering.]
  58. Impact of contraceptive use on birth rate. [Dampak relatif pemakaian kontrasepsi.]
  59. Impact of a self-reliance programme on family planning activities in Bangladesh.
  60. Impact of child mortality on family size desires and family planning practice among white-collar workers.
  61. Impact of contraceptive price on contraceptive choice.
  62. The impact of family planning in Kenya during the last 10 years [editorial]
  63. The impact of family planning on indicators of social well-being. [El impacto de la planificacion familiar en algunos indicadores del bienestar social.]
  64. The impact of family planning on indicators of social well-being. Comment. [El impacto de la planificacion familiar en algunos indicadores del bienestar social. Comentario.]
  65. Improving access to family planning services in rural Mali. Evaluation report, the Centre for Development and Population Activities (CEDPA)
  66. Improving family planning: a decade of FHI's programmatic research.
  67. Income and employment consequences for African-American participants of a family planning clinic: a seven-year follow-up.
  68. 16-hydroxytriptolide, a new active diterpene isolated from Tripterygium Wilford II (male contraceptive)
  69. 1988 Kinshasa Fertility and Family Planning Survey: English summary of highlights.
  70. 1989 Haiti National Contraceptive Prevalence Survey: final English language report.
  71. 1990 Bangladesh NGO family planning fieldwork evaluation survey. Final report.
  72. 1990 International Programs annual report of the Association for Voluntary Surgical Contraception.
  73. The 1991 Mauritius Contraceptive Prevalence Survey.
  74. 5-year contraceptive implant seems headed for wide use.
  75. 6.7% practice family planning. Findings of a baseline survey of knowledge, attitudes and practice in a Tanzanian village.
  76. 75 years of family planning in America: a chronology of major events. Revised ed.
  77. Abortion and contraception. [Aborto y anticoncepcion.]
  78. Abortion and family planning bibliography for 1988.
  79. Abortion regulations and contraception in Prague. [Interrupcni zakon a antikoncepce v Praze.]
  80. Abortion: a public health or a family planning problem. [Aborto: un problema de salud publica o de planificacion familiar.]
  81. The absence of an association between oral contraceptive use and ulcerative colitis in patients [letter]
  82. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
  83. Access to affordable contraception. 1991 report on world progress towards population stabilization.
  84. Access to affordable contraception: 1991 report on world progress towards population stabilization. [Wallchart]
  85. ACLU: strict anti-abortion law could also ban contraceptives.
  86. Actinomycotic vesico-uterine fistula from a wishbone pessary contraceptive device.
  87. Activities to explore. Using drama in AIDS and family planning work.
  88. Adapting data systems of multimethod programs to incorporate natural family planning.
  89. Adding choice to the contraceptive mix: lessons from Indonesia.
  90. Addressing the gap between stated reproductive intentions and contraceptive practices in high risk women.
  91. Adolescent contraceptive use: cues to behavior.
  92. Adolescent pregnancy -- a prospective survey of contraceptive knowledge and reproductive behaviour.
  93. Adolescent women's contraceptive decision making.
  94. Adolescents and oral contraceptives.
  95. Adolescents' perception and use patterns of oral contraceptives.
  96. The Africa Operations Research and Technical Assistance Project: strategies for improving family planning service delivery. Sixth semi-annual report excerpts (April 1 -August 31, 1991)
  97. African men and family planning.
  98. The Afro-American community and the birth control movement, 1918-1942.
  99. Against wind and tide: 25 years of family planning in Colombia. [Contra viento y marea: 25 anos de planificacion familiar en Colombia.]
  100. Agency for International Development Office of Population Seventh Cooperating Agencies Meeting, November 26-28, 1990. Summary of proceedings. Family planning in the 21st century.
  101. The agenda for family planning in the USSR.
  102. AIDS prevention and family planning [letter]
  103. AIDS-related attitudes and knowledge among attenders at a Scottish family planning clinic.
  104. Alternative approaches for delivery of family planning, maternal and child health services.
  105. Alternative estimates of ectopic pregnancy risks during contraception [letter]
  106. Alternative estimates of ectopic pregnancy risks during contraception. Reply [letter]
  107. Alternative methodologies to estimate contraceptive use-failure rates applied to the 1982 National Survey of Family Growth.
  108. An American national experience: natural family planning services under the auspices of the Roman Catholic church.
  109. Analysis of adoption preferences of family planning acceptors through discriminant function.
  110. Analysis of fundamental chains of family planning systematic engineering in the countryside.
  111. Analysis of the 1987 National Indonesia Contraceptive Prevalence Survey: implications for program evaluation and policy formulation.
  112. Analysis of the 1987 National Indonesian Contraceptive Prevalence Survey: implications for program evaluation and policy formulation.
  113. An analysis of the correlation between the fertility rate and the demand for contraceptives.
  114. The analytical potential of Demographic and Health Survey data on coital frequency and its implications for estimation of contraceptive failure rates.
  115. The "anatomy" of Thailand's successful family planning program.
  116. Antibiotic interference with oral contraceptive steroid efficacy.
  117. Antibiotic interference with oral contraceptives.
  118. An approach to effective family planning in rural Egypt.
  119. Are oral contraceptives removed during plasmapheresis?
  120. Ascertaining the user perspectives on community participation in family planning programme in Thailand.
  121. Assessing the reasons for acceptance of modern reversible contraception in rural Bangladesh.
  122. An assessment of counselling for clinical family planning methods in GOB clinic.
  123. An assessment of long-term and permanent contraception: planning for expansion and quality assurance in Zimbabwe, conducted from September 16 to 27, 1991.
  124. Association for Voluntary Surgical Contraception (AVSC) statements about vasectomy and prostate cancer.
  125. Attempt to evaluate a contraceptive method using fuzzy mathematics: a study on the acceptability of Norplant.
  126. Attitude of unmarried girls towards family planning: a study in an Orissa city.
  127. Attitudes and perceptions of family planning practices in rural Mexico: focus group results from Chiapas. [Draft]
  128. Attitudes of family planning nurses.
  129. Attitudes of Hindus and Muslims to family planning.
  130. The attitudes to contraception of Asian women in East London.
  131. Attitudes, communication and family planning: a conceptual framework applicable to Rwanda. [Attitudes, communication et planification familiale: un cadre conceptuel applicable au Rwanda.]
  132. The authors' response to Hogue [Invited Commentary: the Contraceptive Technology Tightrope] [letter]
  133. Availability and use of contraception: a comparative analysis.
  134. Barrier contraceptives, spermicides, and periodic abstinence.
  135. Barrier versus oral contraceptive use: a study of female college students.
  136. Barriers to family planning services among patients in drug treatment programs.
  137. Basic business management for small family planning businesses.
  138. Basic facts about family planning.
  139. Basic premises for the design of the national communication strategy. Institutional communication strategy. Family Planning Unit, MSP. 10 year communication plan for the National Program of Family Health. [Premisas basicas para el diseno de la estrategia nacional de comunicacion. Estrategia institucional de comunicacion. Unidad de Planificacion Familiar, MSP. Plan de comunicacion de 10 anos para el Programa Nacional de Salud Familiar.]
  140. Beneficial effects of oral steroid contraceptives. [Priznive ucinky oralnich steroidnich kontraceptiv.]
  141. Benefits and risk of oral contraceptives: a reassessment.
  142. Benefits and risks of oral contraception. Proceedings of a plenary session at the XII World Congress of Gynaecology and Obstetrics, Singapore, 17 September 1991.
  143. The benefits of family planning insurance.
  144. Benefits of oral contraception: thirty years' experience.
  145. Benign liver tumors and oral contraceptives -- difficulties in diagnosis. [Benigne Lebertumoren und orale Kontrazeptiva -Schwierigkeiten in der Diagnostik.]
  146. Bicycles, sewing machines and family planning.
  147. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
  148. Birth control [letter]
  149. Birth control practice in Great Britain: a review of the evidence from cross-sectional surveys.
  150. Bishops on birth control: a chronicle of obstruction.
  151. Breast cancer risk and oral contraceptive use: results from a large case-control study.
  152. Breastfeeding and birth control [letter]
  153. Breastfeeding and birth control [letter]
  154. Bridging the gender gap in contraception: another hurdle cleared.
  155. Budgeting and financial planning in natural family planning programs: in search of the perfect system.
  156. The campaign for new birth control. Nine conferences in nine cities: a report, January 1990 - January 1991.
  157. Campaigns by religious leaders in rural Gambia influence villagers' knowledge and attitudes towards family planning.
  158. Can combined oral contraceptives be made more effective by means of a nursing care model?
  159. Can family planning services be delivered in time of war? The case of Lebanon.
  160. Carbohydrate metabolic studies in women using a levonorgestrel / ethinyl estradiol containing triphasic oral contraceptive for eighteen months.
  161. Cardiovascular risks of oral contraceptives: dose-response relationship. [Risques cardio-vasculaires des contraceptifs oraux: relation dose-reponse.]
  162. Cardiovascular safety of oral contraceptives: a critical commentary.
  163. The career woman and oral contraceptive use.
  164. The case for family planning.
  165. The case for one brand of injectables within the Bangladesh family planning program.
  166. Cenaplanf; a center for natural family planning in Montevideo, Uruguay. Report from a field trip. [Cenaplanf; ett centra for naturlig familjeplanering i Montevideo, Uruguay. Rapport fran en studieresa.]
  167. Central household -- a good way for family planning in rural areas.
  168. Cerebrovascular disorders and administration of oral contraceptives containing gestodene -- causal relation or coincidence? [Zerebrovaskulare Storungen unter Einnahme gestodenhaltiger oraler Kontrazeptiva -- Kausalitat oder Koinzidenz?]
  169. Cerebrovascular manifestations while taking combined estrogens and progestins for contraceptive purposes. Clinical cases. [Manifestazioni vascolari cerebrali in corso di assunzione di combinazioni estroprogestiniche a scopo contraccettivo. Casistica clinica.]
  170. Cervical cancer and methods of contraception.
  171. Cervical carcinogenesis and contraception.
  172. The challenge of the nineties: family planning directions and the role of operations research.
  173. The challenges of the family planning program. [Los retos del programa de planificacion familiar.]
  174. Change to Tri-Regol from other oral contraceptives.
  175. Changes for merit goods: third world family planning.
  176. Changes in contraceptive use and fertility: El Salvador, 1978-88.
  177. Changes in risk behaviors for women utilizing family planning services located in drug treatment programs.
  178. Changes in the national family planning and fertility surveys in Korea]
  179. Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
  180. Changing pattern of National Family Planning and Fertility Survey in Korea.
  181. The characteristics of private vs. public sector contraceptive users in Indonesia.
  182. Characteristics of school-based and school-linked clinics with and without on-site contraceptive availability.
  183. Characteristics of the new progestogens in combination oral contraceptives.
  184. Child survival and family planning acceptance.
  185. Child survival: the role of family planning. Revised ed.
  186. Children in developing countries -- to die now or to survive in misery? Prolonged breast feeding is good against the "population trap". Family planning should not be forced on developing countries. [Barn i u-land -- do nu eller overleva i misar? Okad amning bra medel mot "befolkningsfallan" familjeplanering far inte pressas pa u-landerna.]
  187. China's birth control policy in the Tibet autonomous region. Myths and realities.
  188. China: accessibility of contraceptives.
  189. Chlamydia trachomatis infection in women and the use of oral contraceptives. [Chlamydia trachomatis-infectie bij de vrouw en het gebruik van orale anticonceptiva.]
  190. Choice of contraception in relation to sexual activity in young women in Nuuk/Godthab (Greenland) and in Nykobing Falster (Denmark). A population-based cross-sectional investigation comprising 1,247 women. [Valg af kontraception i relation til seksuel aktivitet blandt yngre kvinder i Nuuk/Godthab (Gronland) og i Nykobing Falster (Danmark). En populationsbaseret tvaersnitsundersogelse blandt 1.247 kvinder.]
  191. Choosing and using contraception: toward a theory of women's contraceptive self-care.
  192. The civil liability of physicians performing contraceptive sterilization. [La responsabilite civile du medecin et la sterilisation a des fins contraceptives.]
  193. Client flow analysis: a management technique for family planning clinics in Africa.
  194. Clinic-based intervention projects: STD and family planning programs get involved. Intervention model.
  195. Clinical and metabolic effects of the monophasic gestodene / ethinylestradiol pill for contraception during adolescence.
  196. Clinical pharmacokinetic study of Org5187 as a low-dose oral contraceptive.
  197. Clinical pharmacokinetics of contraceptive steroids: an update.

     

  198. Clinical treatment needs and family planning use among women treated for incomplete abortion in teaching hospitals in Nigeria.
  199. Coitus and contraception: the utility of data on sexual intercourse for family planning programs.
  200. Coitus interruptus: considerations as a method of birth control.
  201. Collection of survey data on contraception: an experimental study.
  202. Combined oral contraception -- can we improve efficacy?
  203. Combined progestin and estrogen (oral), and other forms of hormonal contraception.
  204. Communicating with developing country policymakers: the case for natural family planning.
  205. Community based distribution of contraceptives in Kenya: a policy development report.
  206. Community health nurses' knowledge of, attitudes toward, and involvement with adolescent contraceptive services.
  207. Comparative analysis of contraceptive method choice.
  208. A comparative study of characteristics of adolescent and adult family planning acceptors in Lagos.
  209. A comparative study of the Durex Satin diaphragm and the Ortho flat coiled spring diaphragms in two Northern Ireland family planning clinics.
  210. Comparing the health risks and benefits of contraceptive choices.
  211. Comparing the health risks and benefits of contraceptive choices.
  212. Comparison of immunofluorescence and culture for the detection of Actinomyces israelii in wearers of intra-uterine contraceptive devices.
  213. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix.
  214. A comparison of two methodologies for estimating contraceptive use dynamics.
  215. Competency-based approach to training and natural family planning instructor standards.
  216. A comprehensive study of family planning rules of several provinces.
  217. Computerized contraceptive commodities management information system (CCMIS): a tool for improving family planning logistics management: an overview.
  218. Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design.
  219. Conception, contraception: do Algerian women really have a choice?
  220. Concepts of quality of care in family planning: programmatic implications for the Family Planning Services Division, Office of Population.
  221. Condom knowledge and practice: contraception and the prevention of sexually transmitted diseases. [Conhecimento e uso do condom: anticoncepcao e prevencao de doencas sexualmente transmissiveis.]
  222. Condom social marketing can effectively address both AIDS and family planning.
  223. Conference on Consideration of Contraception, Niamey, October 1-4, 1991. Final report. [Journees de Reflexion sur la Contraception, Niamey du 1er au 4 octobre 1991. Rapport final.]
  224. Consistency of condom use for disease prevention among adolescent users of oral contraceptives.
  225. Consultation regarding the problems of contraception in Finland. [Konsultatsiia po voprosam kontratseptsii v Finliandii.]
  226. Content analysis of letters from listeners of "Mwenda Pole Hajikwai" family planning radio magazine programme in Kenya.
  227. Contraception -- a look forward, Part I: New spermicides and natural family planning.
  228. Contraception -- a look forward, Part II: Mifepristone and gossypol.
  229. Contraception -- a look forward, Part III: Inhibin and brain-enhanced estrogen delivery.
  230. Contraception -- natural family planning [letter]
  231. Contraception among urban youth in Nigeria.
  232. Contraception and adolescents, Rhone-Alpes, 1990. [La contraception et les adolescents, Rhone-Alpes 1990.]
  233. Contraception and breast cancer. [Contraception et cancer du sein.]
  234. Contraception and quality of care in Sub-Saharan Africa: application and extension of a framework.
  235. Contraception and sexology. [Contraception et sexologie.]
  236. Contraception and STDs.
  237. Contraception and the adolescent.
  238. Contraception and therapy with Tri Regol tablet.
  239. Contraception at this time of sexually transmitted diseases. [La contraception a l'heure des maladies sexuellement transmissibles.]
  240. Contraception concerns.
  241. Contraception during the postpartum period: perspectives from clients and providers in six countries.
  242. Contraception for the disabled.
  243. Contraception for women with diabetes: an update.
  244. Contraception in adolescents. [Empfangnisverhutung bei Jugendlichen.]
  245. Contraception in Catholic doctrine: the evolution of an earthly code.
  246. Contraception in the perimenopause.
  247. Contraception in women over forty. [La contraccezione nella donna oltre i quarant'anni.]
  248. Contraception methodology manual (training in family planning) [Manual de metodologia anticonceptiva (capacitacion en planificacion familiar)]
  249. Contraception threatened by definition of conception.
  250. Contraception via a vaginal hormonal ring. [Kontratseptsiia posredstvom vlagalishten khormonalen prusten.]
  251. Contraception while breast-feeding [letter]
  252. Contraception with progestogens and progesterone during lactation.
  253. Contraception with subdermal levonorgestrel implants as an alternative to surgical contraception at Ilorin, Nigeria.
  254. Contraception, abortion, and infanticide before modern vital registration. [Kontracepce, aborty a infanticida v pramenech k predstatistickemu obdobi.]
  255. Contraception, family planning, and HIV.
  256. Contraception. Current state of the art.
  257. Contraception: ambiguities and paradoxes. [Contraception: ambiguites et paradoxes.]
  258. Contraception: use and failure.
  259. Contraceptive agents: combination preparations without effect on lipids. Comment. [Antikonzeptiva: kombinierte Praparate ohne Einfluss auf Lipide. Kommentar.]
  260. Contraceptive and health benefits of breastfeeding: a review of the recent evidence.
  261. Contraceptive availability in four Latin American countries.
  262. Contraceptive behaviour of Norwegian adolescents.
  263. Contraceptive choices [letter]
  264. Contraceptive choices -- turning back the clock.
  265. Contraceptive choices for adolescents.
  266. Contraceptive continuation and failure in rural Bangladesh.
  267. The contraceptive effect of breast feeding -- an update [editorial]
  268. The contraceptive effect of breastfeeding.
  269. The contraceptive effect of breastfeeding.
  270. Contraceptive effects of extended lactational amenorrhoea: beyond the Bellagio Consensus.
  271. Contraceptive failure rates in developing countries: evidence from the Demographic and Health Surveys.
  272. Contraceptive failure rates in Turkey. [Turkiye'de gebeligi onleyici yontemlerin kullaniminda basarisizlik hizlari.]
  273. Contraceptive implants approved by the FDA [news]
  274. Contraceptive implants.
  275. Contraceptive information [letter]
  276. Contraceptive management for female adolescents with mental retardation and handicapping disabilities.
  277. Contraceptive method failure and use compliance.
  278. Contraceptive methods and their effectiveness (letter) [Svangerskabsforebyggende metoder og deres effektivitet.]
  279. Contraceptive methods and their efficacy. [Svangerskabsforebyggende metoder og deres effektivitet.]
  280. Contraceptive methods in Eastern Europe. [Les modes de prevention des naissances en Europe de l'Est.]
  281. Contraceptive methods: the probable choice after induced abortion and the pattern on follow up.
  282. Contraceptive needs and demand in developing countries in the 1990s.
  283. Contraceptive needs and logistics management.
  284. Contraceptive options for the gestational diabetic woman.
  285. Contraceptive pill: adequacy of use among women in unions. [Adequacao do uso de pilula anticoncepcional entre mulheres unidas.]
  286. Contraceptive practice doubles in Nigerian city over a five-year period.
  287. Contraceptive prescription: physician beliefs, attitudes and socio-demographic characteristics.
  288. Contraceptive prevalence survey - 1990.
  289. Contraceptive repricing experimentation in four regions of Thailand. Final report.
  290. Contraceptive repricing experimentation in Supanburi, Nakhon Sawan, Nakhon Sri Thammarat, and Surin.
  291. Contraceptive social marketing 1991 sales report.
  292. Contraceptive social marketing in the third world: a case of multiple transfer.
  293. Contraceptive social marketing programs and quality of service: a comparison of pharmacy and clinic-based programs in Egypt.
  294. Contraceptive social marketing sales report, 2nd quarter 1991.
  295. Contraceptive social marketing sales report, 3rd quarter 1991.
  296. Contraceptive source and the for-profit private sector in Third World family planning. Evidence and implications from trends in private sector use in the 1980s.
  297. Contraceptive surgery for men and women. 2nd ed.
  298. Contraceptive use among women admitted with abortion in Nairobi.
  299. Contraceptive use and breast-feeding duration in rural Bangladesh.
  300. Contraceptive use and commodity costs, 1990-2000.
  301. Contraceptive use and fertility in Brazil.
  302. Contraceptive use and its fertility impact in Bangladesh.
  303. Contraceptive use and needs among postpartum women in 25 developing countries: recent patterns and implications.
  304. Contraceptive use discontinuation and failure rates in the Philippines: estimates from the 1986 Contraceptive Prevalence Survey.
  305. Contraceptive use dynamics in Lagos, Nigeria.
  306. Contraceptive use dynamics in Mexico: a follow-up of some reproductive events. [Dinamica del uso de Anticonceptivos en Mexico: el Seguimiento de Algunos Eventos Reproductivos.]
  307. Contraceptive use in random samples of Greenlandic and Danish women -- changes from 1986 to 1988.
  308. Contraceptive use in the year 2000.
  309. Contraceptive use in young women: uptake, availability and education.
  310. Contraceptive use patterns of community family planning volunteers in Indonesia.
  311. The contraceptive vaccine.
  312. Contraceptives / family planning. Which is the best method for me?
  313. Contraceptives and cancer: looking for the evidence.
  314. Contraceptives and minors: the emperor has no clothes.
  315. Contraceptives and systemic lupus erythematosus. Answer to question. [Kontrazeptiva und Lupus erythematodes systematisatus.]
  316. Contraceptives containing gestodene: study demonstrates minimal metabolic effects. [Contraceptivos contendo gestodene: estudo demonstra efeitos metabolicos minimos.]
  317. Contraceptives for teenagers.
  318. Contrasting contraceptive needs.
  319. The contribution of family planning and breastfeeding to birth interval lengths.
  320. Contribution of the Chinese medical mission to family planning in Rwanda. [Contribution de la mission medicale chinoise a la planification familiale au Rwanda.]
  321. Coopting established family planning users as motivators to increase contraceptive acceptor rates.
  322. COPE: a self-assessment technique for improving family planning services.
  323. Corporate family planning.
  324. The correlates of sexual and contraceptive behavior among in-school adolescents in Kenya.
  325. Cost analysis in family planning: operations research projects and beyond.
  326. Cost of public family planning services and scope of private sector provisions.
  327. Cost-benefit model of the Rwanda family planning program. [Modele cout-benefices du programme de planification familiale au Rwanda.]
  328. Cost-effectiveness analysis of family planning programs in rural Bangladesh: evidence from Matlab.
  329. Cost-effectiveness analysis of the family planning program in Korea.
  330. Cost-effectiveness and financial sustainability in family planning operations research.
  331. Counseling about side effects improves contraceptive continuation.
  332. Creating a demand for scientific natural family planning: the Zambian experience.
  333. Critical elements in developing national family planning programs: case studies in operations research.
  334. CSM programs provide contraceptive methods at affordable prices.
  335. Culturally acceptable birth control.
  336. Culture and family planning in a changing society.
  337. Cupid's touch: the lessons of the family planning movement for the AIDS epidemic.
  338. Current contraception among programme beneficiaries.
  339. Current contraceptive status of Chinese women--characteristics and determinants.
  340. Current natural family planning programs and strategies for expanding service delivery: an introduction.
  341. Current status of operations research in natural family planning.
  342. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
  343. Czechoslovakia 1991: abortion and contraception.
  344. The debate on family planning and reproductive rights in Bolivia.
  345. Decisions on strengthening the family planning programme for strict control of population growth by the Central Committee of the Communist Party of China and the State Council.
  346. Decreased contraceptive protection during simultaneous intake of antiepileptics and oral contraceptives? Answer to question. [Verringerter Konzeptionsschutz bei gleichzeitiger Einnahme von Antiepileptika und oralen Kontrazeptiva? Antwort.]
  347. Demand creation factors in family planning.
  348. The demand for family planning in Indonesia 1976 to 1987: a supply-demand analysis.
  349. The demand for family planning: highlights from a comparative analysis.
  350. Demonstrating demand for family planning: creating a supportive environment through operations research.
  351. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  352. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  353. Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  354. Desogestrel: using a selective progestogen in a combined oral contraceptive.
  355. The determinants of contraceptive method and service point choice.
  356. The determinants of contraceptive method and service point choice: evidence from the 1987 National Indonesia Contraceptive Prevalence Survey.
  357. Determinants of contraceptive method choice in an industrial city of India.
  358. Determinants of contraceptive method choice in Sri Lanka: an update of a 1987 survey.
  359. Determinants of contraceptive use dynamics in India: a prospective study.
  360. Determinants of family planning acceptance and fertility change in Kerala: a study on inter-district variations.
  361. Development and characterization of monoclonal antisperm antibodies: potential for contraception.
  362. Development and evaluation of pH sensitive bioerodible polymers for the controlled release of vaginal contraceptive agents.
  363. The diaphragm as a contraceptive (letter) [Pessarium als anticonceptivum.]
  364. Differences between "spacers and stoppers" amongst family planning acceptors in Lagos.
  365. Different contraceptive practices: use of contraceptives in Finland and other Nordic countries in the 1970s and 1980s.
  366. Differentials in contraceptive failure rates in developing countries: results from the Demographic and Health Surveys.
  367. Differentials in contraceptive use among the Karen in Chiang Mai province, northern Thailand.
  368. Directorial Resolution No. 453-91-ITINTEC/DG., approving as a national technical standard Project No. 399.147. Contraceptives devies. Condoms. Means of testing, 18 August 1991. [R.D. No. 453-91-ITINTEC/DG. Aprueba como Norma Tecnica Nacional el Proyecto 399.147 Anticonceptivos Mecanicos. Preservativo Masculino. Condon. Metodos de Ensayo.]
  369. Dis-continuation of contraceptives in Egypt, 1980-1984.
  370. Discontinuation of contraception. [El abandono de la anticoncepcion.]
  371. Diversification is the financial alternative for family planning. [La diversificacion es la alternativa financiera de la planificacion familiar.]
  372. Do oral contraceptives cause breast cancer? [editorial]
  373. Do we need local family planning clinics? The sociodemographic characteristics and views of women attending clinics in Nottingham District.
  374. Does better access to contraceptives increase their use? Key policy and methodological issues.
  375. Does choice make a difference to contraceptive use? Evidence from East Java.
  376. Dominican Republic: implications of the findings of the Demographic and Health Survey, 1986 (DHS-86) for health and family planning policies and programs. [Republica Dominicana: implicaciones de los hallazgos de la DHS-86 para las politicas y programas de salud y planificacion familiar.]
  377. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception.
  378. The duration of contraceptive use.
  379. The dynamics of contraceptive use in developing countries. Pt. 1.
  380. Dynamics of contraceptive use in rural Jiangsu, China.
  381. Early oral contraceptive use and premenopausal breast cancer -- a review of studies performed in southern Sweden.
  382. East Eurowomen call for contraception.
  383. Economic woes mean cuts to family planning services.
  384. Editorial: hormonally-based male contraceptives: will they ever be a reality? [editorial]
  385. Education, fertility and contraception among Hindus and Roman Catholics in Goa.
  386. Effect of antibiotics and oral contraceptive efficacy.
  387. The effect of barrier contraceptives on sexually transmitted diseases in women: a comparison of female-dependent methods with condoms.
  388. Effect of child loss on contraception acceptance.
  389. The effect of child loss on family planning adoption.
  390. The effect of ciprofloxacin on oral contraceptive steroid treatments.
  391. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
  392. Effect of hormonal contraceptives on eicosanoid content of menstrual blood. [Einfluss hormoneller Kontrazeptiva auf den Eicosanoidgehalt des Menstrualblutes.]
  393. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
  394. Effect of physical training on the pharmacokinetics of steroidal contraceptives. [Der Einfluss korperlichen Trainings auf die Pharmakokinetik steroidaler Kontrazeptiva.]
  395. The effect of price increases on contraceptive sales in Bangladesh.
  396. Effect on the venous system and blood coagulation of combined oral estro-progestagen contraceptives and third generation contraceptives. [Action sur le systeme veineux et la crase sanguine des complexes oestro-progestatifs antiovulatoires oraux et de troisieme generation.]
  397. Effective family planning service components: global lessons from operations research.
  398. Effectiveness and acceptability of the symptothermal method of natural family planning in Germany.
  399. Effects of contraceptive counseling on mother's acceptance, continuation rate and side effects of I.U.D. and pill. Summary.
  400. The effects of family planning policy and socioeconomic development on fertility decline in China: 1945-1985.
  401. Effects of low-dose oral contraceptives on female whole saliva.
  402. Effects of oral contraceptive on fibrinogen levels in African women.
  403. Effects of steroid contraceptives on follicular function.
  404. Effects of the triphasic oral contraceptive on lipid and lipoprotein metabolism.
  405. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.

     

  406. Efficacy of combined barrier contraceptives.
  407. Efficacy of the symptothermal method of natural family planning in lactating women after the return of menses.
  408. Efficacy of Veinobiase in venous disorders in combined estrogen-progestagen oral contraceptive users. Statistical study in 2295 patients.
  409. Efficacy studies in natural family planning: issues and management implications illustrated with data from five studies.
  410. Egypt Service Availability Survey 1989. Availability and accessibility of family planning and health services in rural Egypt.
  411. Emergency contraception.
  412. Employer-provided family planning in the private sector: lessons from the Enterprise experience.
  413. Employer-provided family planning in the private sector: the lessons of Enterprise.
  414. Employment, job characteristics, and the use of birth control by sexually active, never-married black, Hispanic, and white women.
  415. Escherichia coli bacteriuria and contraceptive method.
  416. Estimates of contraceptive failure and discontinuation based on two methods of contraceptive data collection in Peru.
  417. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
  418. Evaluation of a prescription based record-linkage model for epidemiological studies of long-term adverse effects of drugs -- with special regard to combined oral contraceptives.
  419. Evaluation of contraception effectiveness of Chinese women.
  420. Evaluation of family planning program.
  421. Evaluation of Matching Grant II to International Planned Parenthood Federation / Western Hemisphere Region (IPPF/WHR) (1987-1992)
  422. Evaluation of natural family planning programs in Liberia and Zambia.
  423. Evaluation of the Central Contraceptive Procurement Project (936-3018), Matrix International Logistics, Inc.
  424. Evaluation of the impact of birth control methods on fertility: the case of Shanghai.
  425. Evaluation of the possible interaction of the antifungal triazole SCH 39304 with oral contraceptives in normal healthy women.
  426. Expanded services for intrauterine contraception in Sudan.
  427. Expanding natural family planning through vocational schools for women in Cote d'Ivoire.
  428. Experience of NGOs and the organized sector in family planning: selected observations.
  429. An experiential approach to training natural family planning trainers.
  430. Exporting abortion politics: the battle over international family planning assistance.
  431. Facilitating corporate investments in family planning and maternal child health services: the TIPPS experience.
  432. Factors affecting contraceptive use in urban Nepal.
  433. Factors associated with Hispanic teenagers' attitude toward the importance of birth control.
  434. Factors associated with sexual and contraceptive behavior among school adolescents in Kenya. The 1989 Nakuru District Adolescent Fertility Survey. Final Report.
  435. Factors related to autonomy and discontinuation of use of natural family planning for women in Liberia and Zambia.
  436. Factors that influence participation of Chinese Indonesian Chinese in the family planning program in Kotamadya Tanjung Balai in 1989.
  437. Family Health International: a perspective on NFP and family planning programs.
  438. Family planning activities in industrial sites.
  439. Family planning adoption, change and discontinuation: a retrospective study from two rural areas of Kenya.
  440. Family planning among lower status women in Rio de Janeiro city. [Planejamento familiar em mulheres de baixa renda no Municipio do Rio de Janeiro.]
  441. Family planning and child survival. The role of reproductive factors in infant and child mortality: an analysis.
  442. Family planning and fertility in southern Appalachia: a community study.
  443. Family planning and induced abortion in the USSR: basic health and demographic characteristics.
  444. Family planning and maternal and child care in present-day society. [Planirovanie semi i zdorove materi i rebenka v sovremennom obshchestve.]
  445. Family planning and perinatal mortality in the Instituto Mexicano del Seguro Social (IMSS) [Planificacion familiar y mortalidad perinatal en el IMSS.]
  446. Family planning and pregnancy counselling projects for young people.
  447. Family planning and prevention strategies for sexually transmitted diseases.
  448. Family planning and protection of human rights.
  449. Family planning and the empowerment of women in Bangladesh.
  450. Family planning and the Gulf war.
  451. Family planning as a determinant of individual and community health. [La planificacion familiar como determinante de salud individual y comunitaria.]
  452. Family Planning Association of Kenya (FPAK) three-year IEC strategy, 1991-1993.
  453. Family planning attitudes, practices and impact of training among private practice physicians in Accra, Ghana.
  454. Family planning availability and contraceptive use in rural Bangladesh: an examination of the distance decay effect.
  455. Family planning behavior, motivation and services using the home-based mother's record in Laguna (HBMR)
  456. Family planning behavior, motivation and services using the home-based mother's record in Pampanga (HBMR)
  457. Family planning clinic provision of STD and HIV services. National questionnaire findings.
  458. Family planning communications in Egypt: a guide for IEC managers.
  459. Family planning differentials by governorate, in Egypt.
  460. Family planning for boat people.
  461. Family planning IEC planning and management.
  462. Family planning in Africa: are men really an obstacle?
  463. Family planning in Bamako, Mali.
  464. Family planning in Czechoslovakia and new methods of contraception. [Planovane rodicovstvi v CSFR a nove moznosti kontracepce.]
  465. Family planning in Indonesia: a tradition for better living.
  466. Family planning in New York. [Lite om familjeplanering i New York.]
  467. Family planning in Oyo State: a report from a pilot client records survey.
  468. Family planning in rural Uganda: knowledge and use of modern and traditional methods in Ankole.
  469. Family planning in urban slum--its analysis and implications.
  470. Family planning information sources and media exposure among Zimbabwean men.
  471. Family planning knowledge, attitudes and practices among health centre personnel in Western Province of Kenya.
  472. Family planning knowledge, attitudes and practices of males in Ilorin, Nigeria.
  473. The family planning manager's handbook. Basic skills and tools for managing family planning programs.
  474. Family planning operations research - Asia. Lessons from the field.
  475. Family planning operations research in Africa: reviewing a decade of experience.
  476. Family planning operations research: a twenty-year research program.
  477. Family planning policy guidelines and standards for service providers.
  478. Family planning posters: differentials in design intention and audience interpretation. Consequences for message effectiveness.
  479. Family planning practice and the law.
  480. Family planning practice and women's fertility decision-making power.
  481. Family planning practices among tribals of South Rajasthan, India.
  482. Family planning priorities in low-prevalence countries.
  483. Family Planning Private Sector Programme: progress report 1990.
  484. Family planning program in Indonesia: a plight for policy reorientation.
  485. Family planning program information system.
  486. Family planning program sustainability experience of Concerned Women for Family Planning.
  487. Family planning programme in Gujarat: a qualitative assessment of inputs and impact.
  488. Family planning programs and birth control in the third world. [Familienplanungsprogramme und Geburtenkontrolle in der Dritten Welt.]
  489. Family planning programs will lead to one-third reduction in developing-world population by 2100.
  490. Family planning programs: efforts and results, 1982-89.
  491. Family planning saves lives. 2nd ed. [La planification familiale sauve des vies. Planificacion familiar: salvando las vidas de madres y ninos.]
  492. Family planning service providers' training needs assessment.
  493. Family planning services: a history of U.S. federal legislation.
  494. A family planning situation analysis study of the Nairobi City Commission clinics.
  495. Family planning target setting and allocation.
  496. Family planning with different contraceptive methods. [Planificarea familiala prin diferite metode contraceptive.]
  497. Family planning, AIDS, and FHI.
  498. Family planning, childbearing and ideal number of children as expressed by mothers of large families. [Csaladtervezes, gyermekvallalas, idealis gyermekszam a sokgyermekes anyak koreben.]
  499. Family planning, fertility decline and child survival.
  500. Family planning, U.S. policy and the deaths in Bangladesh.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.